Technology Platforms

Amneal’s product pipeline represents a diversified range of products across multiple therapeutic areas and dosage forms, including a sizable proportion of complex, high barrier-to-entry and difficult-to-formulate products. It has eight proprietary research and development facilities located in New York, New Jersey and India, focusing on several product categories in various stages of development. The company’s portfolio now includes more than 100 U.S. FDA-approved molecules, more than 100 molecules pending approval and another 200 in development.

The Amneal product pipeline affords broad coverage of therapeutic areas including cardiovascular, central nervous system/pain, oncology, inflammation, anti-infective, dermatology, endocrinology, diabetes, rhinology, urology, and hematology, among others.

Respiratory (Inhalation)
Oral Solids
Device Driven
Oral Liquids